Sökresultat - "Java, J"

Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers

Mysona, D.P., Tran, L.K.H., Tran, P.M.H., Gehrig, P.A., Van Le, L., Ghamande, S., Rungruang, B.J., Java, J., Mann, A.K., Liao, J., Kapp, D.S., Santos, Bruno dos, She, J.X., Chan, J.K.

Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study.

Java, J, Eskander, R, Monk, B, Burger, R, Tewari, Krishnansu

application/pdf

Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study

Tewari, K. S, Java, J. J, Eskander, R. N, Monk, B. J, Burger, R. A

application/pdf

A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy

Previs, R.A., Bevis, K.S., Huh, W., Tillmanns, T., Perry, L., Moore, K., Chapman, J., McClung, C., Kiet, T., Java, J., Chan, J., Secord, A. Alvarez

SIOG2023-5-P-377 - Unsupervised Machine Learning to Understand Symptoms in Older Adults Receiving Chemotherapy

Ramsdale, E., Zhou, Y., Tylock, R., Cacciatore, J., Java, J., Mohile, S.

SIOG2022-0108* - Trajectory of functional decline and loss of independence in activities of daily living (ADL) in older adults with advanced cancer receiving treatment

Culakova, E., Mohile, S., Mohamed, M., Ramsdale, E., Wells, M., Tylock, R., Zhang, Z., Java, J., Gilmore, N., Magnuson, A., Loh, K.P., Peppone, L., Flannery, M.

SIOG2024-3-P-065 Relative dose intensity and survival among older adults with advanced gastrointestinal cancers receiving first line chemotherapy.

Mohamed, M. (AUTHOR), Rich, D. (AUTHOR), Lund, J. (AUTHOR), Seplaki, C. (AUTHOR), Jensen-Battaglia, M. (AUTHOR), Java, J. (AUTHOR), Culakova, E. (AUTHOR), Ramsdale, E. (AUTHOR), Burnette, B. (AUTHOR), Onitilo, A. (AUTHOR), Mohile, S. (AUTHOR)

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Nomogram predicting individual survival following recurrence in advanced stage high-grade ovarian cancer from NRG Oncology/Gynecologic Oncology Group randomized trials of platinum and paclitaxel

Rose, P.G., Java, J., O'Malley, D.M., Geller, M.A., Muggia, F.M., Armstrong, D.K., Bookman, M.A., Brady, M.F., Copeland, L.J.

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study

Rose, P.G., Java, J., Morgan, M.A., Secord, A.A., Kesterson, J., Stehman, F.B., Warshal, D.P., Creasman, W.T., Hanjani, P., Morris, R.T., Copeland, L.J.

Significance of risk-weighted surgical-pathological factors on survival of stage IB cervical cancer: An ancillary analysis of Gynecologic Oncology Group study

Matsuo, K., Java, J., Muderspach, L.I., Roman, L.D., Wright, J.D.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): An NRG Oncology/Gynecologic Oncology Group study

Waggoner, S.E., Java, J., Monk, B.J., Michael, H., Penson, R.T., Leitao, M.M., Coleman, R.L., Mannel, R.S., Oaknin, A., Tewari, K.S.

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact?

Java, J., Nieves-Neira, W., Markman, M., Armstrong, D.K., Pearson, J.M.

Chemotherapy toxicity and quality of life in older women with advanced or recurrent endometrial cancer: An NRG Oncology — Gynecologic Oncology Group ancillary study

Ko, E.M., Java, J., Van Le, L., Schmitz, K., Randall, M.E., Bloss, J.D., Fleming, G., Moore, D.H., Monk, B.J., Muss, H.B.

Complete responses in the irradiated field following treatment with chemotherapy with and without bevacizumab in advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study

Java, J., Monk, B.J., Tewari, K.S.

Impact of treatment-induced neutropenia and thrombocytopenia on survival in patients with advanced ovarian cancer treated with chemotherapy plus bevacizumab: An NRG Oncology/Gynecologic Oncology Group ancillary data study

Java, J., Eskander, R.N., Monk, B.J., Burger, R.A.

Differences in presentation and survival of Asians versus Caucasians with ovarian cancer: A Gynecologic Oncology Group ancillary study of 7914 patients

Java, J., Kapp, D.S., Monk, B.J., Burger, R.A., Young, R.C., Alberts, D.S., McGuire, W.P., Markman, M., Chan, J.K.

The impact of chemotherapy dose density among obese patients with ovarian cancer: A novel assessment of drug dosage relative to patient body surface area

de la Garza, J., Java, J., Lucci, J.A., Ozols, R.F., Spriggs, D., Bookman, M.A., Burger, R.A.